Powered by Smartsupp
Alpha-9 Oncology
Founded
2019
Status
Private
LSVP Investment
2024
Stage Invested
Series C
Lightspeed Team
Dr. Shelley Chu - Partner
-

Alpha-9 Oncology is a clinical-stage biotechnology company developing radiopharmaceuticals for solid and hematologic malignancies. Alpha-9 has a portfolio of molecules entering clinical trials and a robust pipeline of additional targets for future development.

Alpha-9 Oncology
Fraction Fraction

Faction Ventures, L.L.C. ("Faction") and Lightspeed Management Company, L.L.C. ("LSVP") are separate businesses that operate independently of each other. Faction advises its own fund(s) and does not advise any LSVP clients, and LSVP does not advise Faction or any of its clients. LSVP and Faction are parties to an agreement pursuant to which LSVP holds certain interests in Faction and the fund(s) Faction manages.

continue to the Faction Site
INDIA INDIA

Lightspeed Management Company, L.L.C. ("LSVP") and Lightspeed India Partners, L.L.P. ("LSIP") are distinct investment advisory entities, are not a unitary enterprise and operate independently of one another. From time to time LSVP may draw on its relationship with LSIP, and vice versa, but only to the extent consistent with its status as a separate investment adviser.

CONTINUE TO LIGHTSPEED INDIA

Lightspeed Management Company, L.L.C. ("LSVP") and LSIP are distinct investment advisory entities, are not a unitary enterprise and operate independently of one another. From time to time LSVP may draw on its relationship with LSIP, and vice versa, but only to the extent consistent with its status as a separate investment adviser.

Proceed to LSIP company

When changing this filter to include “LSIP”, you will view personnel associated with Lightspeed India Partners, L.L.P ("LSIP")Lightspeed Management Company, L.L.C. ("LSVP") and LSIP are distinct investment advisory entities, are not a unitary enterprise and operate independently of one another. From time to time LSVP may draw on its relationship with LSIP, and vice versa, but only to the extent consistent with its status as a separate investment adviser.

Show LSIP personnel